Showing results (51-60 of 720) with videos related to
Sort By:
Pageof 72
Clinical Chemistry|November 17, 2011
Emerging biomarkers in heart failureRoland R J van Kimmenade, James L JanuzziClinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.The American Journal of Cardiology|February 11, 2015
ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus PanelJames L Januzzi, Alexandre Mebazaa, Salvatore Di SommaThe American Journal of Cardiology|February 11, 2015
ST2 in Pulmonary DiseaseEdnan K Bajwa, Alexandre Mebazaa, James L JanuzziTrends in Cardiovascular Medicine|April 26, 2017
Type 2 myocardial infarction due to supply-demand mismatchNino Mihatov, James L Januzzi, Hanna K GagginJournal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|March 17, 2009
The evolution of the natriuretic peptides - Current applications in human and animal medicineRoland R J van Kimmenade, James L JanuzziEuropean Heart Journal|November 13, 2013
Natriuretic peptide-guided heart failure managementRichard Troughton, G Michael Felker, James L JanuzziJournal of the American College of Cardiology|March 12, 2021
A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical SettingsInbar Raber, Cian P McCarthy, James L JanuzziPsychosomatic Medicine|September 24, 2004
The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart diseaseBettina Bankier, James L Januzzi, Andrew B LittmanJournal of the American College of Cardiology|July 12, 2020
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the WeekYader Sandoval, James L Januzzi, Allan S JaffePageof 72